Lecap Asset Management Ltd. Makes New Investment in Encompass Health Co. (NYSE:EHC)

Lecap Asset Management Ltd. purchased a new stake in Encompass Health Co. (NYSE:EHC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 14,233 shares of the company’s stock, valued at approximately $1,314,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in EHC. State Street Corp raised its holdings in Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after purchasing an additional 21,329 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Encompass Health by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after buying an additional 20,547 shares during the period. Copeland Capital Management LLC raised its stake in Encompass Health by 0.7% during the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock worth $119,418,000 after buying an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. lifted its holdings in Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in Encompass Health by 0.4% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock valued at $71,083,000 after acquiring an additional 2,904 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Trading Up 1.3 %

NYSE:EHC opened at $99.86 on Friday. Encompass Health Co. has a one year low of $72.37 and a one year high of $104.55. The company has a market cap of $10.06 billion, a PE ratio of 24.12, a PEG ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a 50-day moving average of $96.28 and a 200-day moving average of $95.19.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. As a group, equities research analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Barclays boosted their price objective on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday. Royal Bank of Canada increased their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Truist Financial reiterated a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday. Finally, KeyCorp upped their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $107.33.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.